Safety and Efficacy of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in Subjects with T2D, Mild Renal Impairment, and Inadequate Glycemic Control on Metformin (MET) ± a Sulfonylurea (SU)

Category Primary study
Conference78th Scientific Sessions of the American Diabetes Association, ADA 2018
Year 2018
This article has no abstract
Epistemonikos ID: f8ed0587a03f234fae9e53d69784fa8a1ecdcdb3
First added on: Apr 04, 2026